John Gray

John Gray

academic United States

John Gray is a co-author of a recent study from Ohio State University, which revealed that generic drugs manufactured in India are associated with a 54% higher risk of severe adverse events compared to those produced in the United States. As a professor of operations at the Fisher College of Business, Gray emphasizes the significant differences in drug manufacturing regulation and quality assurance practices between emerging economies and advanced economies, shedding light on the complexities of generic drug safety.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
32,412
Power
944$
Sentiment
5.64
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United Kingdom 1 6.00 0.03% +0% 67,886,011 18,060 $2,700,000 718$
Poland 1 5.00 0.04% +0% 37,846,611 14,352 $595,000 226$
Totals 2 105,732,622 32,412 $3,295,000 944$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Spain Spain: John Gray highlights that, despite Trump's brutality, the reality is that under his mandate, the US has become a central and influential power. 6

El País: Europa, Trump y la conquista del Oeste | Opinión

India India: John Gray is a co-author of the study and professor of operations at The Ohio State University’s Fisher College of Business. 7

The Times of India: ‘Are Indian medicines the reason for all the said medical problems?’ Internet erupts as study suggests a 54% higher risk in Indian-made drugs